<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166610">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928772</url>
  </required_header>
  <id_info>
    <org_study_id>14694</org_study_id>
    <nct_id>NCT00928772</nct_id>
  </id_info>
  <brief_title>Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety</brief_title>
  <official_title>The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without
      excessive drowsiness in preoperative settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CES Alpha-Stim is a non-invasive device which has been in place and has been approved for
      patients to reduce anxiety by the FDA. This study involves the use of CES Alpha-Stim device
      applied to the patient 30 minutes before and through-out cataract surgery procedure and then
      to measure the level of anxiety and discomfort by using a visual analog scale (VAS). We
      propose that by applying the device the patients will be able to have markedly less level of
      anxiety and discomfort before and during the surgery and will ultimately avoid the
      traditional use of sedative or analgesic drugs being used for these kinds of surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients sedated with Cranial Electro Stimulation vs traditional sedation with midazolam will have adequate perioperative sedation without side effects related to use of benzodiazepines.</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgeons performing cataract surgery on the patients sedated with Cranial Electro Stimulation rather than midazolam will be more satisfied due to sufficient sedation but less patient's drowsiness and more alertness during the surgery.</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Alpha-Stim intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One hour Alpha-Stim intervention with sham midazolam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Alpha-Stim with midazolam</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Alpha-Stim intervention with real midazolam administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No Alpha-Stim and only topical anesthetics</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM</intervention_name>
    <description>APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
    <arm_group_label>Alpha-Stim intervention</arm_group_label>
    <other_name>AlphaStim</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY</intervention_name>
    <description>CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
    <arm_group_label>Sham Alpha-Stim with midazolam</arm_group_label>
    <other_name>VERSED</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED</intervention_name>
    <description>NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of both genders between 50 and 90 years old scheduled for an outpatient
             &quot;first eye&quot; cataract phacoemulsification with topical anesthesia.

          -  ASA classification I II and III

        Exclusion Criteria:

          -  ASA classification IV (patients with a chronic or severe disease).

          -  Hypersensitivity to midazolam or benzodiazepines

          -  acute narrow-angle glaucoma

          -  untreated open-angle glaucoma

          -  Patients with any sort of psychiatric or neurological disorder

          -  Patients on anti-anxiety medication

          -  Patients who have demand-type pacemakers installed before 1999* *Note: These are the
             exclusions listed for liability purposes by Alpha-Stim. There are no FDA exclusions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grigory Chernyak</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma City VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oklahoma City VA Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>June 25, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cranial Electro Stimulation</keyword>
  <keyword>First Eye Cataract Surgery</keyword>
  <keyword>Preoperative sedation</keyword>
  <keyword>Perioperative sedation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
